Literature DB >> 31741111

ASO Author Reflections: Patient-Reported Outcomes-Bench to Bedside.

Srinivas Joga Ivatury1,2, Sandra L Wong3,4, Deborah Schrag5.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31741111      PMCID： PMC7231622          DOI： 10.1245/s10434-019-07920-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

Authors:  Ethan Basch; Bryce B Reeve; Sandra A Mitchell; Steven B Clauser; Lori M Minasian; Amylou C Dueck; Tito R Mendoza; Jennifer Hay; Thomas M Atkinson; Amy P Abernethy; Deborah W Bruner; Charles S Cleeland; Jeff A Sloan; Ram Chilukuri; Paul Baumgartner; Andrea Denicoff; Diane St Germain; Ann M O'Mara; Alice Chen; Joseph Kelaghan; Antonia V Bennett; Laura Sit; Lauren Rogak; Allison Barz; Diane B Paul; Deborah Schrag
Journal:  J Natl Cancer Inst       Date:  2014-09-29       Impact factor: 13.506

2.  Translation of Patient-Reported Outcomes in Oncology Clinical Trials to Everyday Practice.

Authors:  Srinivas Joga Ivatury; Hannah W Hazard-Jenkins; Gabriel A Brooks; Nadine J McCleary; Sandra L Wong; Deborah Schrag
Journal:  Ann Surg Oncol       Date:  2019-08-26       Impact factor: 5.344

3.  Patients' perceptions and experiences of using a mobile phone-based advanced symptom management system (ASyMS) to monitor and manage chemotherapy related toxicity.

Authors:  L McCann; R Maguire; M Miller; N Kearney
Journal:  Eur J Cancer Care (Engl)       Date:  2009-03       Impact factor: 2.520

4.  Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048.

Authors:  Ethan Basch; Amylou C Dueck; Lauren J Rogak; Sandra A Mitchell; Lori M Minasian; Andrea M Denicoff; Jennifer K Wind; Mary C Shaw; Narre Heon; Qian Shi; Brenda Ginos; Garth D Nelson; Jeffrey P Meyers; George J Chang; Harvey J Mamon; Martin R Weiser; Tatjana Kolevska; Bryce B Reeve; Deborah Watkins Bruner; Deborah Schrag
Journal:  J Clin Oncol       Date:  2018-09-11       Impact factor: 44.544
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.